Target audience
All legal entities interested in collaborative research and innovation actions in the health domain : hospitals, academia, research institutes, industry, enterprises and SMEs, patients' or caregivers' associations, policy makers, SSH
The project
Collaborative consortium of at least three beneficiaries, working together around a research and innovation or coordination and support action, responding to specific challenges mentioned in the topic and implementing the expected outcomes, within a project lasting an average of 3 years.
EU funding
The EU funding covers between 70%-100% of the project costs, plus overhead of 25% of the project budget for indirect expenses.
In each topic, the European commission mentions the indicative budget per project.
Open calls
Call identifier
Deadline
Type of action
Budget overview
Indicative number of grants
European Partnership on Rare Diseases (ERDERA) (Phase 2)
HORIZON-HLTH-2026-02-DISEASE-12
Last date for submission15-09-2026
Other Type
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
HORIZON-HLTH-2027-01-DISEASE-06
Last date for submission13-04-2027
RIA
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
HORIZON-HLTH-2027-01-DISEASE-07
Last date for submission13-04-2027
RIA
Prevention and management of chronic non-communicable diseases in children and young people (GACD)
HORIZON-HLTH-2027-01-DISEASE-10
Last date for submission13-04-2027
RIA
Clinical trials for advancing innovative interventions for neurodegenerative diseases
HORIZON-HLTH-2027-02-DISEASE-14-two-stage
Last date for submission13-04-2027
RIA
Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
HORIZON-HLTH-2027-02-TOOL-01-two-stage
Last date for submission13-04-2027
RIA
Innovative healthcare interventions for non-communicable diseases
HORIZON-HLTH-2027-02-DISEASE-01-two-stage
Last date for submission13-04-2027
RIA
Portable and versatile Point-of-care diagnostics
HORIZON-HLTH-2027-02-IND-02-two-stage
Last date for submission13-04-2027
IA
European Partnership for Pandemic Preparedness (Phase 2)
HORIZON-HLTH-2026-03-DISEASE-13
Last date for submission13-04-2027
Other Type
Addressing disabilities through the life course to support independent living and inclusion
HORIZON-HLTH-2027-01-STAYHLTH-01
Last date for submission13-04-2027
RIA
Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
HORIZON-HLTH-2027-01-DISEASE-05
Last date for submission13-04-2027
RIA
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
HORIZON-HLTH-2027-01-ENVHLTH-02
Last date for submission13-04-2027
RIA
Development of innovative antimicrobials against pathogens resistant to antimicrobials
HORIZON-HLTH-2027-01-DISEASE-08
Last date for submission13-04-2027
RIA
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
HORIZON-HLTH-2027-01-CARE-02
Last date for submission13-04-2027
RIA
Tools and technologies to support health adaptation to climate change
HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03
Last date for submission13-04-2027
Other Type
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
HORIZON-HLTH-2027-01-IND-01
Last date for submission13-04-2027
RIA
Towards Artificial General Intelligence (AGI) for healthcare
HORIZON-HLTH-2027-03-TOOL-08
Last date for submission22-09-2027
CSA
Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
HORIZON-HLTH-2027-03-TOOL-04
Last date for submission22-09-2027
RIA
Advancing bio-printing of living cells for regenerative medicine
HORIZON-HLTH-2027-03-TOOL-02
Last date for submission22-09-2027
RIA